Hot Features
プレミアム
Shattuck Labs Inc (STTK)
NASDAQ
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | OrbiMed Advisors LLC法人 | 1.25M | 0.00 | Open Market Derivative Acquisition | 0.00 | 5.30M | 30.83% |
| 2026-06-09 | Dr. Clay B. SiegallIndependent Director | 62.50k | 250.00k | 買い | 4.00 | 318.61k | 24.40% |
| 2026-05-22 | Dr. Clay B. SiegallIndependent Director | 128.05k | 138.89k | Derivative Exercise and Retained Stock | 1.08 | 256.11k | 100.00% |
| 2026-05-21 | Dr. Abhinav A. ShuklaChief Technical Officer | 5.12k | 5.56k | Derivative Exercise and Retained Stock | 1.08 | 63.14k | 8.83% |
| 2026-05-12 | Dr. Abhinav A. ShuklaChief Technical Officer | -2.03k | 6.99k | Derivative Exercise and Sale | 3.57 - 7.01 | 58.02k | - |
| 2026-05-12 | Dr. Arunthathy Nirmalini PanditeChief Medical Officer | -30.00k | 198.30k | Automatic Disposition | 6.61 | 166.22k | -15.29% |
| 2026-05-12 | Dr. Taylor H. SchreiberCo-Founder, CEO & Director | 25.61k | 27.78k | Derivative Exercise and Retained Stock | 1.08 | 2.73M | 0.95% |
| 2026-05-10 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | -968.00 | 6.63k | Sale to Issuer | 6.85 | 80.56k | -1.19% |
| 2026-01-25 | Dr. Arunthathy Nirmalini PanditeChief Medical Officer | -3.20k | 13.26k | Sale to Issuer | 4.15 | 163.51k | -1.92% |
| 2026-01-25 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | -593.00 | 2.46k | Sale to Issuer | 4.15 | 81.53k | -0.72% |
| 2026-01-25 | Ms. Casi DeYoungChief Business Officer | -2.29k | 9.49k | Sale to Issuer | 4.15 | 43.61k | -4.98% |
| 2026-01-25 | Mr. Andrew R. NeillCFO | -2.59k | 10.74k | Sale to Issuer | 4.15 | 191.24k | -1.34% |
| 2026-01-10 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | -4.15k | 19.73k | Sale to Issuer | 4.75 | 82.12k | -4.81% |
| 2026-01-10 | Ms. Casi DeYoungChief Business Officer | -5.70k | 27.07k | Sale to Issuer | 4.75 | 39.12k | -12.72% |
| 2026-01-10 | Dr. Arunthathy Nirmalini PanditeChief Medical Officer | -6.85k | 32.54k | Sale to Issuer | 4.75 | 157.24k | -4.18% |
| 2026-01-10 | Mr. Andrew R. NeillCFO | -6.66k | 31.64k | Sale to Issuer | 4.75 | 185.10k | -3.47% |
| 2025-08-25 | OrbiMed Advisors LLC法人 | 5.10M | 0.00 | Open Market Derivative Acquisition | 0.00 - 1.08 | 3.07M | -251.97% |
| 2025-08-25 | OrbiMed Advisors LLC法人 | 1.05M | 911.97k | 買い | 0.87 | 1.05M | - |
| 2025-08-25 | OrbiMed Private Investments IX, LP法人 | 5.26M | 4.56M | 買い | 0.87 | 5.26M | - |
| 2025-08-25 | OrbiMed Private Investments IX, LP法人 | 25.48M | 0.00 | Open Market Derivative Acquisition | 0.00 - 1.08 | 15.37M | -251.97% |
| 2025-08-25 | Dr. Stephen StoutGeneral Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | 12.81k | 11.11k | 買い | 0.87 | 86.28k | 17.43% |
| 2025-08-25 | Dr. Clay B. SiegallIndependent Director | 128.05k | 111.11k | 買い | 0.87 | 128.05k | - |
| 2025-08-25 | Mr. Andrew R. NeillCFO | 64.03k | 55.56k | 買い | 0.87 | 169.30k | 60.82% |
| 2025-08-25 | Dr. Taylor H. SchreiberCo-Founder, CEO & Director | 25.61k | 22.22k | 買い | 0.87 | 2.71M | 0.95% |
| 2025-08-25 | Dr. Abhinav A. ShuklaChief Technical Officer | 5.12k | 4.44k | 買い | 0.87 | 37.56k | 15.79% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
